A recent study has revealed that Bharat Biotech’s Covaxin produces neutralising titres against all new key variants of COVID-19 including the double mutant strain B.1.617 and B.1.1.7.
from Zee News :India National https://ift.tt/3hqBUxO
Sunday, May 16, 2021